Where I am at, we have the exact same number of reps as the BI/Lilly group, and also the Merck, and also the Novo. Except OUR BMS territories are LARGER.
Yes, there are a lot of diabetes reps expecially when you count them from all the companies. From a competitive standpoint, we don't have any more reps than anyone else. Quit yer bitchin. If you all think we don't need that many reps, take a hard look at your sales results prior to the additions. Did you keep up with Januvia or Victoza? I'll just answer that for you right now----not even close.
There are plenty of reasons for this, and adding more reps sure may not fix sales, but can you really blame management for that decision? Stupid to blame management for reps having jobs.
Shut up and go sell.